Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “R/R AML”

119 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 119 results

Testing effectiveness (Phase 2)UnknownNCT04762485
What this trial is testing

Humanized CD7 CAR T-cell Therapy for r/r CD7+ Acute Leukemia

Who this might be right for
T Lymphoblastic Leukemia/LymphomaMixed Phenotype Acute LeukemiaAcute Myeloid Leukemia
The First Affiliated Hospital of Soochow University 20
Testing effectiveness (Phase 2)Ended earlyNCT06563804
What this trial is testing

Evaluate S227928 as a Single Agent and in Combination With Venetoclax in Patients With R/R AML, MDS/AML, or CMML

Who this might be right for
Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML)Myelodysplastic Syndrome (MDS)/AMLChronic Myelomonocytic Leukemia (CMML)
Servier Bio-Innovation LLC 13
Early research (Phase 1)Looking for participantsNCT07263906
What this trial is testing

Clinical Study of LILRA6 CAR-T for the Treatment of R/R Acute Myeloid Leukemia

Who this might be right for
Refractory Acute Myeloid LeukemiaRecurrent Acute Myeloid Leukemia
Second Affiliated Hospital, School of Medicine, Zhejiang University 48
Testing effectiveness (Phase 2)Temporarily pausedNCT02462265
What this trial is testing

Oshadi D & Oshadi R Combined With Salvage Chemotherapy for Relapsed Acute Myeloid Leukemia or Lymphoid Leukemia Patients

Who this might be right for
Acute Myeloid LeukemiaLymphoid Leukemia
Oshadi Drug Administration 15
Large-scale testing (Phase 3)Looking for participantsNCT07007312
What this trial is testing

Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML

Who this might be right for
Acute Myeloid Leukemia (AML)
Kura Oncology, Inc. 1,300
Large-scale testing (Phase 3)Looking for participantsNCT06387069
What this trial is testing

Evaluate HMPL-306 in Patients With IDH1or IDH2-mutated Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
Hutchmed 316
Not applicableNot Yet RecruitingNCT06385808
What this trial is testing

Efficacy and Safety of MTBF Conditioning Regimen for Salvageable Allo-HSCT in the Treatment of R/R AML

Who this might be right for
Relapse LeukemiaRefractory Acute Myeloid LeukemiaConditioning+1 more
First Affiliated Hospital Xi'an Jiaotong University 37
Testing effectiveness (Phase 2)Looking for participantsNCT06532058
What this trial is testing

Phase IIa Study to Assess Safety and Efficacy in the Relapsed/Refractory Acute Myeloid Leukemia

Who this might be right for
Relapsed/Refractory Acute Myeloid Leukemia (R/R-AML)
Changzhou Qianhong Bio-pharma Co., Ltd. 53
Testing effectiveness (Phase 2)Study completedNCT02878785
What this trial is testing

Decitabine and Talazoparib in Untreated AML and R/R AML

Who this might be right for
Acute Myeloid Leukemia
University of Maryland, Baltimore 25
Early research (Phase 1)Ended earlyNCT04155580
What this trial is testing

ASTX660 as a Single Agent and in Combination With ASTX727 in Subjects With Relapsed/Refractory Acute Myeloid Leukemia (AML)

Who this might be right for
Acute Myeloid Leukemia
Astex Pharmaceuticals, Inc. 68
Early research (Phase 1)UnknownNCT05463640
What this trial is testing

Evaluate the Safety and Efficacy of ADGRE2 CAR-T in Patients With R/R AML

Who this might be right for
AML
Zhejiang University 20
Early research (Phase 1)Looking for participantsNCT07384715
What this trial is testing

First-in-human (FIH) Trial of GEN3018 in Relapsed or Refractory (R/R) Acute Myeloid Leukemia (AML) or Higher-risk Myelodysplastic Syndrome (HR-MDS)

Who this might be right for
R/R AMLR/R HR-MDSAcute Myeloid Leukemia+1 more
Genmab 78
Testing effectiveness (Phase 2)Looking for participantsNCT07471789
What this trial is testing

Safety and Efficacy of GYA01 (CART84) in Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML) and Acute Lymphoblastic T Leukemia Patients (T-ALL).

Who this might be right for
Acute Myeloblastic LeukaemiaLeukemia, T-Cell
Gyala Therapeutics 33
Large-scale testing (Phase 3)UnknownNCT04716114
What this trial is testing

SKLB1028 Versus Salvage Chemotherapy in Patients With Relapsed or Refractory (R/R) AML With FLT3-Mutated

Who this might be right for
Acute Myeloid Leukemia (AML)
CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 315
Testing effectiveness (Phase 2)WithdrawnNCT06351306
What this trial is testing

DEC-C and Thioguanine for R/R AML

Who this might be right for
Acute Myeloid Leukemia
Columbia University
Large-scale testing (Phase 3)UnknownNCT05175508
What this trial is testing

Aza With or Without ATRA in Newly Diagnosed Unfit AML or Intermediate,High or Very High Risk MDS

Who this might be right for
AMLMDSOld Age; Debility+1 more
The First Affiliated Hospital of Soochow University 180
Testing effectiveness (Phase 2)UnknownNCT03654703
What this trial is testing

Improved Post-Transplant Cyclophosphamide Regimens for Pediatric Patients With Refractory AML

Who this might be right for
Hematopoietic System--Cancer
Capital Research Institute of Pediatrics 100
Early research (Phase 1)Study completedNCT04666649
What this trial is testing

Pegcrisantaspase in Combination With Venetoclax for Treatment of Relapsed or Refractory Acute Myeloid Leukemia (R/R AML)

Who this might be right for
Relapsed or Refractory Acute Myeloid Leukemia
University of Maryland, Baltimore 27
Large-scale testing (Phase 3)Study completedNCT03250338
What this trial is testing

Study Investigating the Efficacy of Crenolanib With Chemotherapy vs Chemotherapy Alone in R/R FLT3 Mutated AML

Who this might be right for
Relapsed/Refractory Acute Myeloid Leukemia With FLT3 Activating Mutations
Arog Pharmaceuticals, Inc. 106
Early research (Phase 1)Study completedNCT04839341
What this trial is testing

Study to Evaluate PK and Safety With Uproleselan Combined With Chemotherapy to Treat Chinese R/R AML Patients

Who this might be right for
Relapsed/Refractory AML
Apollomics Inc. 12
Load More Results